Adaptive Biotechnologies (ADPT) Goodwill & Intangibles (2018 - 2026)

Adaptive Biotechnologies has disclosed Goodwill & Intangibles across 9 years of filings, most recently posting $120.3 million for Q1 2026.

• Goodwill & Intangibles for Q1 2026 came in at $120.3 million, down 1.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $120.3 million (down 1.39% YoY), and the FY2025 annual result was $120.7 million, down 13.35% from the prior year.
• Goodwill & Intangibles came in at $120.3 million for Q1 2026 at Adaptive Biotechnologies, roughly flat from $120.7 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $139.3 million in Q1 2022 to a low of $120.3 million in Q1 2026.
• The 5-year median for Goodwill & Intangibles is $124.5 million (2023), against an average of $127.8 million.
• Across the five-year window, Goodwill & Intangibles increased 9.25% in 2022 and fell 13.35% in 2025, its largest moves.
• Adaptive Biotechnologies' Goodwill & Intangibles stood at $139.3 million in 2022, then changed by 0.0% to $139.3 million in 2023, then changed by 0.0% to $139.3 million in 2024, then dropped by 13.35% to $120.7 million in 2025, then fell by 0.35% to $120.3 million in 2026.
• The last three Goodwill & Intangibles figures came in at $120.3 million (Q1 2026), $120.7 million (Q4 2025), and $121.1 million (Q3 2025), per Business Quant data.